Literature DB >> 12391255

TCR gamma delta+ and CD161+ thymocytes express HIV-1 in the SCID-hu mouse, potentially contributing to immune dysfunction in HIV infection.

Kevin B Gurney1, Otto O Yang, S Brian Wilson, Christel H Uittenbogaart.   

Abstract

The vast diversity of the T cell repertoire renders the adaptive immune response capable of recognizing a broad spectrum of potential antigenic peptides. However, certain T cell rearrangements are conserved for recognition of specific pathogens, as is the case for TCRgammadelta cells. In addition, an immunoregulatory class of T cells expressing the NK receptor protein 1A (CD161) responds to nonpeptide Ags presented on the MHC-like CD1d molecule. The effect of HIV-1 infection on these specialized T cells in the thymus was studied using the SCID-hu mouse model. We were able to identify CD161-expressing CD3(+) cells but not the CD1d-restricted invariant Valpha24/Vbeta11/CD161(+) NK T cells in the thymus. A subset of TCRgammadelta cells and CD161-expressing thymocytes express CD4, CXCR4, and CCR5 during development in the thymus and are susceptible to HIV-1 infection. TCRgammadelta thymocytes were productively infectable by both X4 and R5 virus, and thymic HIV-1 infection induced depletion of CD4(+) TCRgammadelta cells. Similarly, CD4(+)CD161(+) thymocytes were depleted by thymic HIV-1 infection, leading to enrichment of CD4(-)CD161(+) thymocytes. Furthermore, compared with the general CD4-negative thymocyte population, CD4(-)CD161(+) NK T thymocytes exhibited as much as a 27-fold lower frequency of virus-expressing cells. We conclude that HIV-1 infection and/or disruption of cells important in both innate and acquired immunity may contribute to the overall immune dysfunction seen in HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391255     DOI: 10.4049/jimmunol.169.9.5338

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2.

Authors:  Nina Ank; Klavs Petersen; Lene Malmgaard; Søren C Mogensen; Søren R Paludan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection.

Authors:  Dong Sung An; Betty Poon; Raphael Ho Tsong Fang; Kees Weijer; Bianca Blom; Hergen Spits; Irvin S Y Chen; Christel H Uittenbogaart
Journal:  Clin Vaccine Immunol       Date:  2007-02-21

3.  Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy.

Authors:  Michael A Poles; Shady Barsoum; Wenjie Yu; Jian Yu; Patricia Sun; Jeanine Daly; Tian He; Saurabh Mehandru; Andrew Talal; Martin Markowitz; Arlene Hurley; David Ho; Linqi Zhang
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  EBV promotes human CD8 NKT cell development.

Authors:  Yuling He; Ruijing Xiao; Xiang Ji; Li Li; Lang Chen; Jie Xiong; Wei Xiao; Yujuan Wang; Lijun Zhang; Rui Zhou; Xinti Tan; Yongyi Bi; Yan-Ping Jiang; Youxin Jin; Jinquan Tan
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

5.  Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7.

Authors:  Johan K Sandberg; Cheryl A Stoddart; Fabienne Brilot; Kimberly A Jordan; Douglas F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 6.  γδ T Cells in HIV Disease: Past, Present, and Future.

Authors:  C David Pauza; Bhawna Poonia; Haishan Li; Cristiana Cairo; Suchita Chaudhry
Journal:  Front Immunol       Date:  2015-01-30       Impact factor: 7.561

Review 7.  γδ T-cell responses during HIV infection and antiretroviral therapy.

Authors:  Jennifer A Juno; Emily M Eriksson
Journal:  Clin Transl Immunology       Date:  2019-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.